跳至主要内容
临床试验/JPRN-jRCT2080221835
JPRN-jRCT2080221835未知2 期

A randomized, double-blind, placebo-controlled, comparative study of HP-3000 in patients with Parkinson's disease taking L-DOPA

Hisamitsu Pharmaceutical Co.,Inc.0 个研究点开始时间: 2012年6月21日最近更新:
适应症

试验速览

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 <= 79age old(—)
性别
All

入选标准

  • Patients diagnosed with Parkinson's disease in stages 2 to 4 on the modified Hoehn & Yahr scale

排除标准

  • - Patients with history of hypersensitivity to ropinirole
  • - Patients with clinically significant renal impairment or hepatic dysfunction
  • - Patients who have cutaneous abnormality at planned application site that can be worsen by application with investigational product

研究者

相似试验